Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Windlas Biotech Ltd. Share Price
Day's Range
Day's Range
Low
₹841.15
High
₹865.70
Price Summary
| Previous Close | ₹861.25 |
|---|---|
| Day's Range | ₹841.15 - ₹865.70 |
| Open | ₹857.90 |
| 52 Week Range | ₹697.40 - ₹1,097.90 |
| Volume | 63,491 |
| Market Cap | ₹0.00 |
| Previous Close | ₹861.00 |
|---|---|
| Day's Range | ₹847.25 - ₹867.00 |
| Open | ₹861.00 |
| 52 Week Range | ₹699.35 - ₹1,095.00 |
| Volume | 2,901 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 546.82 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.73 |
| Price/Earning (TTM) | 26.75 |
| TTM EPS (₹) | 32.20 |
| P/E Ratio | 35.78 |
| Book Value(₹) | 3.33 |
| PAT Margin (%) | 8.03 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 17.12 |
| Trade Value ( ₹ in Lacs) | 24.98 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.73 |
| Price/Earning (TTM) | 26.75 |
| TTM EPS (₹) | 32.20 |
| P/E Ratio | 35.78 |
| Book Value(₹) | 3.33 |
| PAT Margin (%) | 8.03 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 17.12 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 2027.05 | 7598.78 |
| Expenses | N/A | N/A |
| PBT | 208.23 | 797.58 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 162.81 | 609.94 |
About Windlas Biotech Ltd.
| Founded | 2001 |
|---|---|
| Managing Director | Hitesh Windlass |
| NSE Symbol | WINDLAS |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,49,047.54 | 1,870.85 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,77,179.04 | 6,674.20 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,57,803.57 | 4,662.35 | 3,287.30 - 3,287.30 |
| Apollo Hospitals Enterprise Ltd. | 1,25,057.42 | 8,743.05 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,17,642.47 | 1,456.25 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,12,368.23 | 1,340.55 | 1,148.40 - 1,148.40 |
| Max Healthcare Institute Ltd. | 1,09,728.37 | 1,127.45 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 1,09,690.51 | 1,102.00 | 835.50 - 835.50 |
| Lupin Ltd. | 1,09,676.37 | 2,394.00 | 1,836.80 - 1,836.80 |
| Mankind Pharma Ltd. | 1,02,728.62 | 2,480.00 | 1,909.70 - 1,909.70 |
No Records Found
Latest News
Windlas Biotech submits AGM notice
Windlas Biotech informs about board meeting
Windlas Biotech has informed that a meeting of the Board of Directors of the Company will be held on April 17, 2026, inter-alia, to consider and approve the proposal for buyback of its fully paid-up equity shares of the company and the matters necessary and incidental thereto, in accordance with the applicable provisions of the Companies Act, 2013, including rules framed thereunder, the Securities and Exchange Board of India (Buy-Back of Securities) Regulations, 2018, as amended, and other applicable laws.
The above information is a part of company’s filings submitted to BSE.
Alkem Laboratories informs about newspaper advertisement
Pursuant to Regulation 30 and 47 read alongwith Schedule III of the SEBI LODR Regulations, Alkem Laboratories has informed that it enclosed a copy of advertisement published in today's newspapers, Business Standard (English) and Mumbai Lakshadeep (Marathi) for information regarding 52nd Annual General Meeting of the Company to be held through video conferencing (VC)/ other audio visual means (OAVM). The same is also available on the website of the Company at www.alkemlabs.com.
The above information is a part of company’s filings submitted to BSE.
Dr. Lal PathLabs informs about newspaper publication
Jubilant Pharmova informs about compliances-certificate
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Windlas Biotech Ltd. is ₹861.25 as of 2026-07-02.
The market capitalisation of Windlas Biotech Ltd. is ₹1,777.60 as of 2026-07-02.
The 1-year return of Windlas Biotech Ltd. is -28.95% as of 2026-07-02.
The P/E ratio of Windlas Biotech Ltd. is 23.43 as of 2026-07-02.
The 52-week high and low of Windlas Biotech Ltd. are ₹1,097.90 and ₹697.40, respectively, as of 2026-07-02.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
